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Objective: The impact of obesity or associated metabolic risk factors on left 
ventricular (LV) diastolic dysfunction (DD) may be modest in comparison to 
the effects of co-morbidities, such as increases in blood pressure (BP). We 
aimed to assess whether the impact of obesity (or associated insulin resis-
tance) on LV diastolic function is enhanced by the presence of concentric LV 
remodelling.
Design and method: Echocardiographic LV mass index (LVMI), relative wall 
thickness (RWT) and diastolic function (ratio of early-to-late transmitral blood 
fl ow velocity (E/A) and E/the mean of lateral and septal wall myocardial tissue 
lengthening at the level of the mitral annulus [e¢] [E/e’] [n = 430]) were deter-
mined in 737 randomly recruited participants of a community-based study with a 
high prevalence of excess adiposity (43% obese).
Results: Independent of LVMI and confounders, indexes of adiposity and 
the homeostasis model of insulin resistance (HOMA-IR) were modestly, 
but independently associated with E/A (p = 0.01), and E/e’ (p = 0.01). In 
addition, RWT was similarly modestly, but independently associated with 
E/A (p < 0.005), and E/e’ (p = 0.005). Importantly, independent of the in-
dividual terms and additional confounders (including LVMI), an interac-
tion between HOMA-IR and RWT was related to E/A and E/e’ (p < 0.05). 
This translated into a signifi cant independent relationship between HOMA-
IR and E/A (partial r = –0.17, p < 0.002) and between HOMA-IR and E/e’ 
(partial r = 0.19, p < 0.01) in those with a RWT above the median for the 
sample, but a lack of relationship between HOMA-IR and E/A (partial 
r = 0.01, p = 0.79) and between HOMA-IR and E/e’ (partial r = –0.004, 
p = 0.98) in those with a RWT below the median for the sample. Similarly, 
HOMA-IR was independently associated with LV diastolic dysfunction in 
those with a RWT above (p < 0.05) but not below (p > 0.19) the median for 
the sample.
Conclusions: The relationship between insulin resistance and LV diastolic func-
tion, and hence possibly the progression to heart failure with a preserved ejection 
fraction in obesity, may be markedly modifi ed by the presence of concentric LV 
remodelling.
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Objective: The unfavourable effects of the association of obesity with hyperten-
sion on cardiac structure and function have been extensively studied. However, 
controversy still exists about the infl uence of gender on the relationship between 
obesity and left ventricular mass (LVM) and hypertrophy (LVH). Even if body 
mass index (BMI) and waist circumference (WC) are widely used as anthropo-
metric predictors for cardiovascular diseases (CVD), their validity has been ques-
tioned. Recently, Body Shape Index (ABSI) and Body Roundness Index (BRI) 
were proposed as alternative measures of adiposity that may better refl ect health 
status (1–2). Our study was aimed to assess the ability of ABSI and BRI in identify-
ing LVH and to determine whether they are superior to BMI and WC. Moreover, the 
infl uence of gender on the relationships between all these indices of adiposity and 
LVM was also evaluated.
Design and method: We enrolled 724 subjects with EH (mean age 45 ± 12 
years, 63% men) without cardiovascular complications. In all subjects the an-
thropometric indices (weight, height and waist circumference) and the routine 
biochemical parameters were determined. BMI, ABSI and BRI were calcu-
lated. Furthermore, all patients underwent a 24-h blood pressure monitoring 
and an echocardiogram. LVM was indexed for body surface area (LVMI) and 
for height2.7 (LVMH2.7).
Results: The univariate correlations of LVMI and LVMH2.7 with the measures of 
adiposity evaluated are shown in the table 1. ROC curves analysis revealed that in 
overall population (table 2) and in men BRI has a greater ability to identify LVH 
defi ned as LVMH2.7 > 51 g/m2.7.
Conclusions: Our results seems to suggest that in men, but not in women, the BRI 
has a greater sensitivity to detect LVH than ABSI and the traditional measures of 
adiposity.
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Objective: Chemerin is recently identifi ed adipose hormone, which plays a role in 
adipogenesis, energy metabolism and infl ammation. Increased levels of chemerin 
have been linked to obesity and development of diabetes mellitus. During the 
transition from premenopause to postmenopause, many women experience weight 
gain and central fat deposition, hence we hypothesized that circulating level of 
chemerin can play a role in the pathogenesis of hypertension and cardiometabolic 
risk in postmenopausal females.
Design and method: Methods: The study included 80 women (mean age 57.6 
± 5.4 years), 54 subjects with arterial hypertension and 26 normotensive age 
matched controls. In all subjects anthropometrical measurements and 24-hr 
ABPM were performed. Fasting blood samples were taken for glucose, insulin 
and serum lipids concentration. Serum levels of chemerin, nesfatin and obestatin 
were measured using an immunochemical assay. Asymptomatic organ damages 
were analyzed including echocardiographic examination with assessment of 
left ventricular mass (LVM), (GE Vivid 7.0); carotid ultrasound with measure-
ment of intima-media thickness (IMT), and carotid-femoral pulse wave velocity 
measurement(PWV) (Sphygmocor).
Results: Results: Compared with controls, subjects with hypertension had higher 
serum chemerin levels (147,8 ± 29,7 vs 132,2 ± 23,6; p = 0,05). Nesfatin and 
obestatin concentrations did not differ between hypertensive and normotensive 
groups. Chemerin was signifi cantly associated with metabolic characteristics in-
cluding BMI (r = 0,32, p = 0,003), waist circumference (r = 0,48, p = 0,0001), 
fasting glucose (r = 0,27, p = 0,02), and triglycerides (r = 0,20, p = 0.07). In 
logistic regression analysis, chemerin concentration was an independent predic-
tor of the presence of hypertension, but the association lost its signifi cance after 
adjustment for BMI.
Conclusions: Conclusions: In postmenopausal women serum chemerin is inde-
pendently associated with left ventricular mass, left atrial volume and components 
of metabolic syndrome. Association of chemerin with hypertension is mediated 
by body adiposity.
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